13F-HR filed by Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB filed this 13F-HR for the quarter ended 2014-12-31, filed 2015-02-09, with 84 holding rows worth $345,008,000.
- Accession
- 0001415889-15-000450
- Filer
- CIK 1599882
- Filed
- 2015-02-09
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2014
A holdings report, 84 entries on the cover page, a total value of $345,008,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $345,008,000 with VALUE read as thousands by filing date, 13F file number 028-15944. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CELGENE CORP | 151020104 | COM | 182,000 | $20,359,000 | thousands by filing date | |
| Gilead Sciences,Inc. | 375558103 | COM | 206,138 | $19,431,000 | thousands by filing date | |
| CVS Health Corporation | 126650100 | COM | 97,000 | $9,342,000 | thousands by filing date | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 22,500 | $9,231,000 | thousands by filing date | |
| AbbVie,Inc. | 00287Y109 | COM | 140,000 | $9,162,000 | thousands by filing date | |
| ALKERMES PLC | G01767105 | SHS | 143,000 | $8,374,000 | thousands by filing date | |
| ALEXION PHARMACEUTICALS INC | 015351109 | COM | 44,000 | $8,141,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 21,500 | $7,298,000 | thousands by filing date | |
| MEDIVATION INC | 58501N101 | COM | 70,700 | $7,042,000 | thousands by filing date | |
| ACTAVIS PLC | G0083B108 | SHS | 27,000 | $6,950,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 115,000 | $6,788,000 | thousands by filing date | |
| UNIVERSAL TECHNICAL INST INC | 913915104 | COM | 61,000 | $6,787,000 | thousands by filing date | |
| UnitedHealth Group Inc | 91324P102 | COM | 67,000 | $6,773,000 | thousands by filing date | |
| RECEPTOS, INC. | 756207106 | COMMON STOCK | 52,526 | $6,435,000 | thousands by filing date | |
| Amgen Inc. | 031162100 | COM | 39,168 | $6,239,000 | thousands by filing date | |
| ESPERION THERAPEUTICS INC NEW COM | 29664W105 | Stock | 150,000 | $6,066,000 | thousands by filing date | |
| RITEAID CORP | 767754104 | COM | 785,000 | $5,903,000 | thousands by filing date | |
| COVIDIEN PLC | G2554F113 | SHS | 57,000 | $5,830,000 | thousands by filing date | |
| CARDINAL HEALTH INC | 14149Y108 | COM | 70,000 | $5,651,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 61,000 | $5,514,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 165,000 | $5,239,000 | thousands by filing date | |
| Elevance Health, Inc. | 036752103 | COM | 41,000 | $5,152,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 85,398 | $4,782,000 | thousands by filing date | |
| Catamaran Corp | 14887102 | COM | 92,000 | $4,761,000 | thousands by filing date | The CUSIP as filed is malformed. |
| Eli Lilly and Company | 532457108 | COM | 66,000 | $4,553,000 | thousands by filing date | |
| Merck & Co.,Inc. | 58933Y105 | COM | 80,000 | $4,543,000 | thousands by filing date | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 38,000 | $4,514,000 | thousands by filing date | |
| ACHILLION PHARMACEUTICALS IN | 00448Q201 | COM | 368,000 | $4,508,000 | thousands by filing date | |
| SALIX PHARMACEUTICALS INC | 795435106 | COM | 38,000 | $4,368,000 | thousands by filing date | |
| CELLADON CORP | 15117E107 | Cmn | 196,000 | $3,828,000 | thousands by filing date | |
| NEKTAR THERAPEUTICS | 640268108 | COM | 238,000 | $3,689,000 | thousands by filing date | |
| CENCORA INC COM | 03073E105 | Stock | 40,000 | $3,606,000 | thousands by filing date | |
| DEXCOM INC COM | 252131107 | Stock | 64,000 | $3,523,000 | thousands by filing date | |
| COMMUNITY HEALTH SYSTEMS INC | 203668108 | COMMON STOCK | 64,000 | $3,451,000 | thousands by filing date | |
| INTERCEPT PHARMACEUTICALS IN | 45845P108 | COM | 22,000 | $3,432,000 | thousands by filing date | |
| MCKESSON CORP COM | 58155Q103 | Stock | 16,000 | $3,321,000 | thousands by filing date | |
| INCYTE CORP COM | 45337C102 | Stock | 44,000 | $3,217,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B103 | COM | 175,000 | $3,194,000 | thousands by filing date | |
| NPS PHARMACEUTICALS INC | 62936P103 | COM | 89,000 | $3,184,000 | thousands by filing date | |
| HCA Healthcare Inc | 40412C101 | COM | 41,000 | $3,009,000 | thousands by filing date | |
| THORATEC CORP | 885175307 | COM | 92,000 | $2,986,000 | thousands by filing date | |
| ENDOLOGIX INC | 29266S106 | COM | 194,000 | $2,966,000 | thousands by filing date | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 28,000 | $2,908,000 | thousands by filing date | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 17,400 | $2,849,000 | thousands by filing date | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 159,854 | $2,821,000 | thousands by filing date | |
| CEPHEID | 15670R107 | COM | 52,000 | $2,815,000 | thousands by filing date | |
| BECTON DICKINSON & CO | 075887109 | COM | 20,142 | $2,803,000 | thousands by filing date | |
| HEARTWARE INTL INC | 422368100 | COM | 38,000 | $2,790,000 | thousands by filing date | |
| ABIOMED INC | 003654100 | COM | 73,000 | $2,778,000 | thousands by filing date | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 22,000 | $2,756,000 | thousands by filing date | |
| ARIAD PHARMACEUTICALS INC | 04033A100 | COM | 397,000 | $2,727,000 | thousands by filing date | |
| AUXILIUM PHARMACEUTICALS INC | 05334DAA5 | NOTE 1.500% 7/1 | 77,000 | $2,648,000 | thousands by filing date | |
| MACROGENICS INC | 556099109 | COM | 75,000 | $2,630,000 | thousands by filing date | |
| ST JUDE MED INC | 790849103 | COM | 40,000 | $2,601,000 | thousands by filing date | |
| ISIS PHARMACEUTICALS INC | 464330109 | COM | 42,000 | $2,593,000 | thousands by filing date | |
| ARRAY BIOPHARMA INC COM | 04269X105 | Stock | 545,000 | $2,578,000 | thousands by filing date | |
| AMSURG CORP | 03232P405 | COM | 47,000 | $2,572,000 | thousands by filing date | |
| MEDTRONIC INC | 585055106 | COM | 35,000 | $2,527,000 | thousands by filing date | |
| HOLOGIC INC | 436440101 | COM | 94,000 | $2,514,000 | thousands by filing date | |
| AETNA INC NEW | 00817Y108 | COM | 28,000 | $2,487,000 | thousands by filing date | |
| CERNER CORP | 156782104 | COM | 38,000 | $2,457,000 | thousands by filing date | |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 19,000 | $2,420,000 | thousands by filing date | |
| INSULET CORP COM | 45784P101 | Stock | 52,000 | $2,395,000 | thousands by filing date | |
| TESARO INC | 881569107 | COM | 62,651 | $2,330,000 | thousands by filing date | |
| OLD REP INTL CORP COM | 680223104 | Stock | 70,000 | $2,318,000 | thousands by filing date | |
| OREXIGEN THERAPEUTICS INC | 686164104 | COMMON STOCK | 375,000 | $2,273,000 | thousands by filing date | |
| Tandem Diabetes Care, Inc. | 875372104 | COM | 179,000 | $2,273,000 | thousands by filing date | |
| PHARMACYCLICS INC | 716933106 | COM | 18,500 | $2,262,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 23,000 | $2,231,000 | thousands by filing date | |
| CYBERONICS | 23251P102 | COMMON STOCK | 40,000 | $2,227,000 | thousands by filing date | |
| REVANCE THERAPEUTICS INC | 761330109 | COM | 126,574 | $2,144,000 | thousands by filing date | |
| SUPERNUS PHARMACEUTICALS | 868459108 | COM | 250,800 | $2,082,000 | thousands by filing date | |
| LIGAND PHARMACEUTICALS INC | 53220K504 | COM NEW | 39,000 | $2,075,000 | thousands by filing date | |
| DYNAVAX TECHNOLOGIES CORP | 268158102 | COM | 122,835 | $2,071,000 | thousands by filing date | |
| KITE PHARMA INC | 49803L109 | COM | 35,000 | $2,018,000 | thousands by filing date | |
| OMNICARE INC | 681904108 | COM | 25,000 | $1,823,000 | thousands by filing date | |
| MYRIAD GENETICS INC | 62855J104 | COM | 50,000 | $1,703,000 | thousands by filing date | |
| LEXICON PHARMACEUTICALS INC | 528872104 | COM | 1,594,805 | $1,451,000 | thousands by filing date | |
| KERYX BIOPHARMACEUTICALS | 492515101 | COMMON STOCK | 90,424 | $1,279,000 | thousands by filing date | |
| Mirati Therapeutics Inc | 60449T107 | COM | 45,388 | $841,000 | thousands by filing date | |
| XENCOR INC | 98401F105 | COMMON STOCK | 50,000 | $802,000 | thousands by filing date | |
| BIND THERAPEUTICS INC | 05548N107 | Cmn | 133,535 | $721,000 | thousands by filing date | |
| THRESHOLD PHARMACEUTICAL INC | 885807206 | COM NEW | 201,537 | $641,000 | thousands by filing date | |
| ANTHERA PHARMACEUTCLS INC | 03674U201 | Common equity shares | 400,000 | $632,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001415889-15-000450 | this filing | 2015-02-09 | acceptance time not in the bulk data set |